Gross margin from -€75,241 to -€18,764Loss of €28,035Merger: absorbed by BISC GLOBAL BV17-07Merger proposal: to be absorbed by BV BISC GLOBAL13-05Equity from -€32,751 to -€60,786Debts from €219,221 to €279,240
Key points
from the 2024 annual accounts, the last ones filed
Merger proposal: to be absorbed by BV BISC GLOBAL
Permanent representatives: Maarten BRASPENNING and Jan GHYSSAERT · EXCELRA B.V. holds 12,501 shares · Anandbir Singh BRAR holds 2 shares · Gazette deed
Merger proposal: to be absorbed by BV BISC GLOBAL
Permanent representatives: Maarten BRASPENNING and Jan GHYSSAERT · EXCELRA B.V. holds 12,500 shares · The company holds 18,600 shares of BV BISC GLOBAL · Board meeting of 11-12-2023 · Gazette deed
1 director appointed, 2 resignations
Resignations: BMBK Invest BV and Ghyssaert Genetics CommV · Permanent representatives: Maarten Braspenning and Jan Ghyssaert · Appointment: Anandbir Singh Brar (sole director) · General meeting of 07-04-2023 · Gazette deed
Absorbed by BV BISC GLOBALmerger by absorption, July 2024
Activity
“Het beleggen, het intekenen op, vast overnemen, plaatsen, kopen, verkopen en verhandelen van aandelen…” (deed in Dutch)From the articles, 10 activitiesNo NACE code in the KBO yet